RAPID-CRISPR: highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemia

Acute promyelocytic leukemia (APL), distinguished by the presence of PML::RARA fusion transcript, is a medical emergency because of its high early death rate, which is preventable when diagnosed early. Current diagnostic methods are precise and reliable but are time intensive, require sophisticated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Maity, Akash (VerfasserIn) , Sathyanarayanan, Amritha (VerfasserIn) , Kumar, Rohit (VerfasserIn) , Vora, Jesal (VerfasserIn) , Gawde, Jitendra (VerfasserIn) , Jain, Hasmukh (VerfasserIn) , Bagal, Bhausaheb (VerfasserIn) , Subramanian, P. G. (VerfasserIn) , Sengar, Manju (VerfasserIn) , Khattry, Navin (VerfasserIn) , Patkar, Nikhil (VerfasserIn) , Hasan, Syed K. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 11 FEBRUARY 2025
In: Blood advances
Year: 2025, Jahrgang: 9, Heft: 3, Pages: 463-472
ISSN:2473-9537
DOI:10.1182/bloodadvances.2024014539
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/bloodadvances.2024014539
Volltext
Verfasserangaben:Akash Maity, Amritha Sathyanarayanan, Rohit Kumar, Jesal Vora, Jitendra Gawde, Hasmukh Jain, Bhausaheb Bagal, P.G. Subramanian, Manju Sengar, Navin Khattry, Nikhil Patkar, and Syed K. Hasan

MARC

LEADER 00000caa a2200000 c 4500
001 1930499396
003 DE-627
005 20250913141731.0
007 cr uuu---uuuuu
008 250715s2025 xx |||||o 00| ||eng c
024 7 |a 10.1182/bloodadvances.2024014539  |2 doi 
035 |a (DE-627)1930499396 
035 |a (DE-599)KXP1930499396 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Maity, Akash  |e VerfasserIn  |0 (DE-588)1371549648  |0 (DE-627)193050523X  |4 aut 
245 1 0 |a RAPID-CRISPR  |b highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemia  |c Akash Maity, Amritha Sathyanarayanan, Rohit Kumar, Jesal Vora, Jitendra Gawde, Hasmukh Jain, Bhausaheb Bagal, P.G. Subramanian, Manju Sengar, Navin Khattry, Nikhil Patkar, and Syed K. Hasan 
264 1 |c 11 FEBRUARY 2025 
300 |b Illustrationen, Diagramme 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 29. Januar 2025 
500 |a Gesehen am 15.07.2025 
520 |a Acute promyelocytic leukemia (APL), distinguished by the presence of PML::RARA fusion transcript, is a medical emergency because of its high early death rate, which is preventable when diagnosed early. Current diagnostic methods are precise and reliable but are time intensive, require sophisticated instruments, and analytical expertise. This study has redefined APL identification by CRISPR system (RAPID-CRISPR) to rapidly (<3 hours) detect PML::RARA. APL cell lines (NB4 and UF-1) and bone marrow/peripheral blood samples from 74 patients with APL (66/8, retrospective/prospective) and 48 controls were included in the study. We used a DETECTR (DNA endonuclease-targeted CRISPR transreporter) assay to identify the bcr1, bcr2, and bcr3 PML::RARA isoforms. To ensure high specificity, we used PML::RARA-specific loop-mediated isothermal amplification (LAMP) primers, synthetic protospacer-adjacent motif sites, and isoform-specific CRISPR RNAs. RAPID-CRISPR recognized APL with 100% sensitivity and 100% specificity in an ambispective cohort of patient samples. Furthermore, our blinded validation approach to detect PML::RARA in an unbiased manner provides an additional layer in the diagnostic precision of APL. RAPID-CRISPR demonstrated superior sensitivity, detecting as few as 1 copy of PML::RARA compared with 10 copies by the gold-standard reverse transcriptase qualitative and quantitative polymerase chain reaction. The nucleic acid extraction-free protocol combined with the 1-step reverse transcriptase LAMP-based DETECTR followed by lateral flow readout makes the RAPID-CRISPR assay suitable for diagnosing APL in point-of-care settings. This simple, cost-effective tool, with its easy-to-read format, is particularly valuable in underresourced regions. The assay facilitates timely diagnosis and prompt administration of lifesaving therapies such as all-trans retinoic acid and arsenic trioxide in APL. 
700 1 |a Sathyanarayanan, Amritha  |e VerfasserIn  |0 (DE-588)1371549362  |0 (DE-627)1930501676  |4 aut 
700 1 |a Kumar, Rohit  |e VerfasserIn  |4 aut 
700 1 |a Vora, Jesal  |e VerfasserIn  |4 aut 
700 1 |a Gawde, Jitendra  |e VerfasserIn  |4 aut 
700 1 |a Jain, Hasmukh  |e VerfasserIn  |4 aut 
700 1 |a Bagal, Bhausaheb  |e VerfasserIn  |4 aut 
700 1 |a Subramanian, P. G.  |e VerfasserIn  |4 aut 
700 1 |a Sengar, Manju  |e VerfasserIn  |4 aut 
700 1 |a Khattry, Navin  |e VerfasserIn  |4 aut 
700 1 |a Patkar, Nikhil  |e VerfasserIn  |4 aut 
700 1 |a Hasan, Syed K.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Blood advances  |d Washington, DC : American Society of Hematology, 2016  |g 9(2025), 3 vom: Feb., Seite 463-472  |h Online-Ressource  |w (DE-627)873588312  |w (DE-600)2876449-3  |w (DE-576)48043249X  |x 2473-9537  |7 nnas  |a RAPID-CRISPR highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemia 
773 1 8 |g volume:9  |g year:2025  |g number:3  |g month:02  |g pages:463-472  |g extent:10  |a RAPID-CRISPR highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemia 
856 4 0 |u https://doi.org/10.1182/bloodadvances.2024014539  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250715 
993 |a Article 
994 |a 2025 
998 |g 1371549362  |a Sathyanarayanan, Amritha  |m 1371549362:Sathyanarayanan, Amritha  |d 60000  |d 60200  |d 60260  |e 60000PS1371549362  |e 60200PS1371549362  |e 60260PS1371549362  |k 0/60000/  |k 1/60000/60200/  |k 2/60000/60200/60260/  |p 2 
999 |a KXP-PPN1930499396  |e 474634566X 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online veröffentlicht: 29. Januar 2025","Gesehen am 15.07.2025"],"language":["eng"],"recId":"1930499396","person":[{"family":"Maity","given":"Akash","display":"Maity, Akash","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Amritha","family":"Sathyanarayanan","role":"aut","display":"Sathyanarayanan, Amritha","roleDisplay":"VerfasserIn"},{"given":"Rohit","family":"Kumar","role":"aut","roleDisplay":"VerfasserIn","display":"Kumar, Rohit"},{"role":"aut","display":"Vora, Jesal","roleDisplay":"VerfasserIn","given":"Jesal","family":"Vora"},{"role":"aut","display":"Gawde, Jitendra","roleDisplay":"VerfasserIn","given":"Jitendra","family":"Gawde"},{"role":"aut","display":"Jain, Hasmukh","roleDisplay":"VerfasserIn","given":"Hasmukh","family":"Jain"},{"role":"aut","display":"Bagal, Bhausaheb","roleDisplay":"VerfasserIn","given":"Bhausaheb","family":"Bagal"},{"given":"P. G.","family":"Subramanian","role":"aut","display":"Subramanian, P. G.","roleDisplay":"VerfasserIn"},{"display":"Sengar, Manju","roleDisplay":"VerfasserIn","role":"aut","family":"Sengar","given":"Manju"},{"roleDisplay":"VerfasserIn","display":"Khattry, Navin","role":"aut","family":"Khattry","given":"Navin"},{"role":"aut","display":"Patkar, Nikhil","roleDisplay":"VerfasserIn","given":"Nikhil","family":"Patkar"},{"family":"Hasan","given":"Syed K.","display":"Hasan, Syed K.","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title":"RAPID-CRISPR","subtitle":"highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemia","title_sort":"RAPID-CRISPR"}],"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen, Diagramme"}],"relHost":[{"title":[{"title":"Blood advances","title_sort":"Blood advances"}],"pubHistory":["Vol. 1, iss. 1 (November 2016)-"],"part":{"extent":"10","volume":"9","text":"9(2025), 3 vom: Feb., Seite 463-472","pages":"463-472","issue":"3","year":"2025"},"note":["Gesehen am 27.04.21"],"disp":"RAPID-CRISPR highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemiaBlood advances","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"873588312","language":["eng"],"origin":[{"dateIssuedDisp":"[2016]-","publisher":"American Society of Hematology","publisherPlace":"Washington, DC"}],"id":{"issn":["2473-9537"],"zdb":["2876449-3"],"eki":["873588312"]},"name":{"displayForm":["American Society of Hematology"]},"physDesc":[{"extent":"Online-Ressource"}]}],"name":{"displayForm":["Akash Maity, Amritha Sathyanarayanan, Rohit Kumar, Jesal Vora, Jitendra Gawde, Hasmukh Jain, Bhausaheb Bagal, P.G. Subramanian, Manju Sengar, Navin Khattry, Nikhil Patkar, and Syed K. Hasan"]},"origin":[{"dateIssuedDisp":"11 FEBRUARY 2025","dateIssuedKey":"2025"}],"id":{"eki":["1930499396"],"doi":["10.1182/bloodadvances.2024014539"]}} 
SRT |a MAITYAKASHRAPIDCRISP1120